Impact of essential genes on the success of genome editing experiments generating 3313 new genetically engineered mouse lines

Hillary Elrick,Kevin A. Peterson,Brandon J. Willis,Denise G. Lanza,Elif F. Acar,Edward J. Ryder,Lydia Teboul,Petr Kasparek,Marie-Christine Birling,David J. Adams,Allan Bradley,Robert E. Braun,Steve D. Brown,Adam Caulder,Gemma F. Codner,Francesco J. DeMayo,Mary E. Dickinson,Brendan Doe,Graham Duddy,Marina Gertsenstein,Leslie O. Goodwin,Yann Hérault,Lauri G. Lintott,K. C. Kent Lloyd,Isabel Lorenzo,Matthew Mackenzie,Ann-Marie Mallon,Colin McKerlie,Helen Parkinson,Ramiro Ramirez-Solis,John R. Seavitt,Radislav Sedlacek,William C. Skarnes,Damien Smedley,Sara Wells,Jacqueline K. White,Joshua A. Wood,International Mouse Phenotyping Consortium,Shaheen Akhtar,Alasdair J. Allan,Susan Allen,Philippe André,Daniel Archer,Sarah Atkins,Ruth Avery,Abdel Ayadi,Daniel Barrett,Tanya Beyetinova,Toni Bell,Melissa Berry,Katharina Boroviak,Joanna Bottomley,Tim Brendler-Spaeth,Ellen Brown,Jonathan Burvill,James Bussell,Charis Cardeno,Rebecca V. Carter,Patricia Castellanos-Penton,Skevoulla Christou,Greg Clark,Shannon Clarke,James Cleak,Ronnie Crawford,Amie Creighton,Maribelle Cruz,Ozge Danisment,Charlotte Davis,Joanne Doran,Valérie Erbs,Qing Fan-Lan,Rachel Fell,He Feng,Jean-Victor Fougerolle,Alex Fower,Gemma Frake,Martin D. Fray,Antonella Galli,David Gannon,Wendy J. Gardiner,Angelina Gaspero,Diane Gleeson,Chris Godbehere,Evelyn Grau,Mark Griffiths,Nicola Griggs,Kristin Grimsrud,Sarah Hazeltine,Marie Hutchison,Catherine Ingle,Vivek Iyer,Kayla Jager,Joanna Joeng,Susan Kales,Perminder Kaur,Janet Kenyon,Jana Kopkanova,Christelle Kujath,Helen Kundi,Peter Kutny,Valerie Laurin,Sandrine Lejeay,Christopher Lelliott,Jorik Loeffler,Romain Lorentz,Christopher V. McCabe,Elke Malzer,Peter Matthews,Ryea Maswood,Matthew McKay,Terrence Meehan,David Melvin,Alison Murphy,Asif Nakhuda,Amit Patel,Ilya Paulavets,Guillaume Pavlovic,Ashley Pawelka,Fran J. Pike,Radka Platte,Peter D. Price,Kiran Rajaya,Shalini Reddy,Whitney Rich,Barry Rosen,Victoria Ross,Mark Ruhe,Luis Santos,Laurence Schaeffer,Alix Schwiening,Mohammed Selloum,Debarati Sethi,Jan R. Sidiangco,Caroline Sinclair,Elodie Sins,Gillian Sleep,Tania Sorg,Becky Starbuck,Michelle Stewart,Holly Swash,Mark Thomas,Sandra Tondat,Rachel Urban,Jana Urbanova,Susan Varley,Dominque Von Schiller,Hannah Wardle-Jones,Lauren Weavers,Michael Woods,Stephen A. Murray,Jason D. Heaney,Lauryl M. J. Nutter

DOI: https://doi.org/10.1038/s41598-024-72418-8

IF: 4.6

2024-10-02

Scientific Reports

Abstract:The International Mouse Phenotyping Consortium (IMPC) systematically produces and phenotypes mouse lines with presumptive null mutations to provide insight into gene function. The IMPC now uses the programmable RNA-guided nuclease Cas9 for its increased capacity and flexibility to efficiently generate null alleles in the C57BL/6N strain. In addition to being a valuable novel and accessible research resource, the production of 3313 knockout mouse lines using comparable protocols provides a rich dataset to analyze experimental and biological variables affecting in vivo gene engineering with Cas9. Mouse line production has two critical steps – generation of founders with the desired allele and germline transmission (GLT) of that allele from founders to offspring. A systematic evaluation of the variables impacting success rates identified gene essentiality as the primary factor influencing successful production of null alleles. Collectively, our findings provide best practice recommendations for using Cas9 to generate alleles in mouse essential genes, many of which are orthologs of genes linked to human disease.

multidisciplinary sciences